Literature DB >> 29528913

Community-acquired Pneumonia With Pleural Effusion in Children and Municipal Human Development Index in Rio de Janeiro, Brazil.

Marcelo Land1, Paula Maia1, Maria de Fátima March1, Alvaro Ferreira2, Clemax Sant Anna1.   

Abstract

BACKGROUND: This study evaluated admissions with severe community-acquired pneumonia (CAP) with pleural effusion (PE) in a pediatric university hospital and the impact of the increased average municipal human development index (M-HDI) in the local incidence of the disease in the last decade.
METHODS: This is a retrospective longitudinal study of patients (0-13 years old) with CAP. The municipal human development index (M-DHI) of the place of residence of patients was obtained. We calculate the crude odds ratios (ORs) of variables related to risk of developing PE. The variables that reached a significance level of 80% (P < 0.20) were selected for multivariate analysis. The logistic regression model was used for the selection of the parsimonious model, according to the likelihood ratio.
RESULTS: The 465 patients' ages ranged from 1 to 174 months. The median of age (months) in children with PE was 36.00; in children without the PE was 29.00 (P < 0.011); media of variation in M-HDI in the period in patients with PE was 0.767 ± 0.002 and in patients without PE was 0.778 ± 0.002 (P < 0.001). In the logistic regression model, the absence of comorbidity (OR = 2.909) and the HDI < 0.770 (OR = 3.015) were predictive factors associated with PE.
CONCLUSION: The progressive increase of the M-DHI during the study period, although to a slightly higher level, was correlated with the reduction in the number of admissions with CAP with PE.

Entities:  

Mesh:

Year:  2018        PMID: 29528913     DOI: 10.1097/INF.0000000000001980

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  1 in total

1.  Geographically linked risk factors for enrolment into a fast breathing child pneumonia trial in Lilongwe, Malawi: an Innovative Treatments in Pneumonia (ITIP) secondary analysis.

Authors:  Evangelyn Nkwopara; Robert Schmicker; Tisungane Mvalo; Susanne May; Amy Sarah Ginsburg
Journal:  BMJ Open Respir Res       Date:  2019-05-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.